focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Regulatory News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.00
Bid: 6.76
Ask: 7.50
Change: 1.24 (21.53%)
Spread: 0.74 (10.947%)
Open: 5.72
High: 7.22
Low: 5.72
Prev. Close: 5.76
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

23 Feb 2007 15:16

Synairgen plc23 February 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of Synairgen plcexisting shares to which voting rights are attached: 2. Reason for the notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights ( ) An acquisition or disposal of financial instruments which may result in the ( )acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights ( ) Other (please specify): Confirmation of our Xholding___________________________________ 3. Full name of person(s) subject to the AMVESCAP plcnotification obligation: 4. Full name of shareholder(s) (if differentfrom 3.): 5. Date of the transaction (and date on whichthe threshold is crossed or reached ifdifferent): 6. Date on which issuer notified: 23 February 2007 7. Threshold(s) that is/are crossed or reached: 5%, 6% 8. Notified details: - A: Voting rights attached to sharesClass/type of Situation previous to the Resulting situation after the triggering transactionshares Triggering transaction if possible Number of Number of Number of Number of voting % of voting rightsusing the ISIN Shares Voting Rights shares rightsCODE Direct Direct Indirect Direct Indirect Ordinary 1p 1,314,211 1,314,211 1,314,211 1,314,211 6.05%Shares(GB00B0381Z20) B: Financial InstrumentsResulting situation after the triggering transactionType of financial Expiration date Exercise/ Conversion Number of voting rights % of votinginstrument Period/ Date that may be acquired if rights the instrument is exercised/ converted. - Total (A+B)Number of voting rights % of voting rights1,314,211 6.05% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectivelyheld, if applicable: Chase Nominees - 743,836 Vidacos Nominees - 570,375 Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold votingrights: 13. Additional information: 14. Contact name: John Ward 15. Contact telephone number: 02380 512800 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Jul 20203:13 pmRNSHolding(s) in Company
28th Jul 20209:01 amRNSHolding(s) in Company
27th Jul 20209:06 amRNSSecond Price Monitoring Extn
27th Jul 20209:00 amRNSPrice Monitoring Extension
23rd Jul 20204:40 pmRNSSecond Price Monitoring Extn
23rd Jul 20204:36 pmRNSPrice Monitoring Extension
22nd Jul 20202:05 pmRNSHolding(s) in Company
21st Jul 20204:15 pmRNSHolding(s) in Company
21st Jul 20207:00 amRNSHolding(s) in Company
21st Jul 20207:00 amRNSClarification Regarding COVID-19 Trial
20th Jul 20204:40 pmRNSSecond Price Monitoring Extn
20th Jul 20204:35 pmRNSPrice Monitoring Extension
20th Jul 202011:05 amRNSSecond Price Monitoring Extn
20th Jul 202011:00 amRNSPrice Monitoring Extension
20th Jul 20209:05 amRNSSecond Price Monitoring Extn
20th Jul 20209:00 amRNSPrice Monitoring Extension
20th Jul 20207:00 amRNSPositive results from trial in COVID-19 patients
15th Jul 20208:00 amRNSHolding(s) in Company
3rd Jul 202012:43 pmRNSHolding(s) in Company
3rd Jul 202012:38 pmRNSHolding(s) in Company
29th Jun 20203:18 pmRNSResult of AGM
22nd Jun 20204:41 pmRNSSecond Price Monitoring Extn
22nd Jun 20204:36 pmRNSPrice Monitoring Extension
19th Jun 20207:00 amRNSGrant of Options
18th Jun 20207:00 amRNSNational expansion of home-based COVID-19 trial
17th Jun 20204:40 pmRNSSecond Price Monitoring Extn
17th Jun 20204:36 pmRNSPrice Monitoring Extension
12th Jun 20202:01 pmRNSPrice Monitoring Extension
10th Jun 20205:32 pmRNSHoldings in Company
10th Jun 20205:27 pmRNSHoldings in Company
10th Jun 202010:46 amRNSHolding(s) in Company
3rd Jun 20204:21 pmRNSAnnual Report and Notice of Annual General Meeting
28th May 20207:00 amRNSRecruitment of Patients in SG016 Trial Completed
26th May 20207:00 amRNSInitiation of SNG001 in home setting
26th May 20207:00 amRNSPreliminary results for the year ended 31 Dec 2019
11th May 20205:41 pmRNSHolding(s) in Company
6th May 20205:07 pmRNSHolding(s) in Company
5th May 202011:05 amRNSSecond Price Monitoring Extn
5th May 202011:00 amRNSPrice Monitoring Extension
30th Apr 202012:09 pmRNSExtension of clinical study in COVID-19 patients
28th Apr 20205:16 pmRNSHolding(s) in Company
24th Apr 20205:10 pmRNSHolding(s) in Company
16th Apr 20205:35 pmRNSHolding(s) in Company
15th Apr 20201:30 pmRNSHolding(s) in Company
14th Apr 20202:06 pmRNSSecond Price Monitoring Extn
14th Apr 20202:00 pmRNSPrice Monitoring Extension
14th Apr 202012:00 pmRNSResult of General Meeting
14th Apr 202011:06 amRNSSecond Price Monitoring Extn
14th Apr 202011:00 amRNSPrice Monitoring Extension
14th Apr 20209:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.